Erythropoietin (EPO) 11096-26-7: A Comprehensive Guide to Its Applications and Benefits

Discover the therapeutic power of Erythropoietin (EPO) with CAS 11096-26-7. As a leading pharmaceutical material, EPO plays a critical role in treating various forms of anemia and supporting critical medical procedures. Learn how this vital compound can benefit patients and healthcare providers.

Get a Quote & Sample

Advantages Provided by the Product

Anemia Treatment Efficacy

Experience the effectiveness of Erythropoietin in treating anemia. By stimulating red blood cell production, it directly addresses the core issue, offering a solution for patients with kidney failure anemia and other related conditions. Its role in cancer anemia treatment is vital for patient well-being.

Supportive Therapy for Chronic Conditions

EPO serves as crucial supportive therapy for chronic conditions like HIV/AIDS. Its ability to improve the anemia associated with these diseases enhances the overall treatment regimen and patient outcomes. This makes it a vital component for comprehensive care.

Surgical Blood Management

Our Erythropoietin can prevent blood loss during operations and promote autotransfusion. This strategic use of EPO is critical for surgical patients, reducing the need for transfusions and improving recovery times. It's a key element in effective blood management strategies.

Key Applications

Anemia Treatment

EPO is a cornerstone in the treatment of anemia, particularly for patients suffering from kidney failure, cancer, or myelodysplastic syndrome. Reliable Erythropoietin manufacturer China offers this solution.

HIV/AIDS Supportive Care

The compound is used to treat anemia associated with HIV/AIDS, improving the quality of life for patients undergoing complex treatment regimens.

Surgical Blood Loss Prevention

EPO's ability to mitigate blood loss during surgery and support autotransfusion makes it invaluable in surgical settings.

Myelodysplastic Syndrome Management

It provides therapeutic benefits for individuals diagnosed with myelodysplastic syndrome, helping to manage their blood cell production issues.